Garcia R, Thibault G, Gutkowska J, Cantin M
Clin Exp Hypertens A. 1986;8(7):1127-47. doi: 10.3109/10641968609045478.
Conscious two-kidney, one-clip (2-K, 1-C) hypertensive rats and their normotensive sham-operated controls were infused during 13 days with synthetic ANF (Arg 101 - Tyr 126) at 35 pmol/hr/rat by means of osmotic minipumps connected to the jugular vein. The initial blood pressure of 186 +/- 6 mmHg maximally decreased to 118 +/- 7 mmHg at day 5 and slowly rose afterwards without reaching basal values. A concomitant drop in pressure natriuresis and diuresis was observed. No changes were observed in ANF-infused sham-operated rats. Urinary aldosterone excretion declined in ANF-treated rats from a basal value of 63.38 +/- 21.04 micrograms/24 hr to 13.36 +/- 3.78 micrograms/24 hr the last infusion day. No change in urinary aldosterone was observed in either non-infused 2-K, 1-C or ANF-infused sham-operated rats. Plasma aldosterone was significantly higher only in non-treated 2-K, 1-C rats. Renal aldosterone clearance was significantly lower in ANF-infused 2-K, 1-C rats than in the other experimental groups. Plasma renin activity (PRA) was lower in treated (3.92 +/- 2.26 AI ng/ml/hr) than in non-treated (9.08 +/- 2.32 AI ng/ml/hr) hypertensive rats, and not different from ANF-infused or non-infused sham-operated rats. No differences in body weight between infused and non-infused rats, or hematocrit between any group were observed. Atrial immunoreactive ANF was not different in any group. These results demonstrate that chronic administration of ANF not only reduces blood pressure and PRA in 2-K, 1-C hypertensive rats but also plasma and urinary aldosterone. Whether the latter is a direct inhibitory effect or secondary to the normalization of PRA is not known. The hypotensive response may be due to a direct effect on vascular smooth muscle but a role of renin cannot be excluded. Because blood pressure returned toward basal values during the last days of the observation period, the possibility of a tachyphylactic effect of ANF on vascular smooth muscle cannot be excluded.
清醒的双肾单夹(2-K,1-C)高血压大鼠及其血压正常的假手术对照组,通过连接颈静脉的渗透微型泵,以35皮摩尔/小时/大鼠的剂量持续13天输注合成心钠素(Arg 101 - Tyr 126)。初始血压为186±6 mmHg,在第5天时最大降至118±7 mmHg,之后缓慢上升但未达到基础值。同时观察到压力性利钠和利尿作用下降。在输注心钠素的假手术大鼠中未观察到变化。在心钠素治疗组大鼠中,尿醛固酮排泄量从基础值63.38±21.04微克/24小时降至最后输注日的13.36±3.78微克/24小时。在未输注心钠素的2-K,1-C大鼠或输注心钠素的假手术大鼠中,尿醛固酮均未发生变化。仅在未治疗的2-K,1-C大鼠中血浆醛固酮显著升高。在心钠素输注的2-K,1-C大鼠中,肾醛固酮清除率显著低于其他实验组。治疗组高血压大鼠的血浆肾素活性(PRA)(3.92±2.26 AI纳克/毫升/小时)低于未治疗组(9.08±2.32 AI纳克/毫升/小时),且与输注或未输注心钠素的假手术大鼠无差异。在输注和未输注心钠素的大鼠之间体重无差异,且任何组之间的血细胞比容也无差异。任何组的心房免疫反应性心钠素均无差异。这些结果表明,在心钠素对2-K,1-C高血压大鼠的长期给药不仅降低血压和PRA,而且还降低血浆和尿醛固酮。后者是直接抑制作用还是继发于PRA的正常化尚不清楚。降压反应可能是由于对血管平滑肌的直接作用,但肾素的作用也不能排除。由于观察期最后几天血压恢复至基础值,因此不能排除心钠素对血管平滑肌产生快速耐受性效应的可能性。